v3.26.1
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock Series B [Member]
Common Stock [Member]
Subscription Receivable [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Common Stock Before RS [Member]
Beginning balance, value at Jul. 31, 2024 $ 8 $ 211 $ 0 $ 963,683 $ (222,071) $ 48,179 $ 790,010  
Shares, Outstanding, Beginning Balance at Jul. 31, 2024 80,000 2,111,686 [1]           14,781,803
Net loss (93,056) 1,108 (91,948)  
Ending balance, value at Oct. 31, 2024 $ 8 $ 211 0 963,683 (315,127) 49,287 698,062  
Shares, Outstanding, Ending Balance at Oct. 31, 2024 80,000 2,111,686 [1]           14,781,803
Beginning balance, value at Jul. 31, 2024 $ 8 $ 211 0 963,683 (222,071) 48,179 790,010  
Shares, Outstanding, Beginning Balance at Jul. 31, 2024 80,000 2,111,686 [1]           14,781,803
Net loss             (1,162,328)  
Ending balance, value at Apr. 30, 2025 $ 8 $ 236 0 5,846,922 (1,376,465) 40,245 4,510,946  
Shares, Outstanding, Ending Balance at Apr. 30, 2025 80,000 2,361,686 [1]           16,531,803
Beginning balance, value at Oct. 31, 2024 $ 8 $ 211 0 963,683 (315,127) 49,287 698,062  
Shares, Outstanding, Beginning Balance at Oct. 31, 2024 80,000 2,111,686 [1]           14,781,803
Net loss (113,351) 2,380 (110,971)  
Ending balance, value at Jan. 31, 2025 $ 8 $ 211 0 963,683 (428,478) 51,667 587,091  
Shares, Outstanding, Ending Balance at Jan. 31, 2025 80,000 2,111,686 [1]           14,781,803
Net loss (947,987) (11,422) (959,409)  
Proceeds from public offering $ 25 4,724,827 4,724,852  
Stock Issued During Period, Shares, New Issues   250,000 [1]           1,750,000
Warrants issuance to consultant 158,412 158,412  
Ending balance, value at Apr. 30, 2025 $ 8 $ 236 0 5,846,922 (1,376,465) 40,245 4,510,946  
Shares, Outstanding, Ending Balance at Apr. 30, 2025 80,000 2,361,686 [1]           16,531,803
Beginning balance, value at Jul. 31, 2025 $ 8 $ 236 0 5,846,922 (2,862,860) 2,611 2,986,917  
Shares, Outstanding, Beginning Balance at Jul. 31, 2025 80,000 2,361,763           16,531,803
Net loss (268,098) (776) (268,874)  
Ending balance, value at Oct. 31, 2025 $ 8 $ 236 0 5,846,922 (3,130,958) 1,835 2,718,043  
Shares, Outstanding, Ending Balance at Oct. 31, 2025 80,000 2,361,763           16,531,803
Beginning balance, value at Jul. 31, 2025 $ 8 $ 236 0 5,846,922 (2,862,860) 2,611 2,986,917  
Shares, Outstanding, Beginning Balance at Jul. 31, 2025 80,000 2,361,763           16,531,803
Net loss             (594,453)  
Ending balance, value at Apr. 30, 2026 $ 0 $ 361 0 6,134,805 (3,482,130) 27,428 2,680,464  
Shares, Outstanding, Ending Balance at Apr. 30, 2026 0 3,618,907           25,331,803
Beginning balance, value at Oct. 31, 2025 $ 8 $ 236 0 5,846,922 (3,130,958) 1,835 2,718,043  
Shares, Outstanding, Beginning Balance at Oct. 31, 2025 80,000 2,361,763           16,531,803
Net loss (399,898) (17,226) (417,124)  
Conversion of preferred stock to common stock $ (8) $ 114 (106)  
Stock Issued During Period, Shares, Conversion of Convertible Securities (80,000) 1,142,858           8,000,000
Issuance common stock for inventory purchase $ 11 287,989 288,000  
Stock Issued During Period, Shares, Other   114,286           800,000
Ending balance, value at Jan. 31, 2026 $ 0 $ 361 0 6,134,805 (3,530,856) (15,391) 2,588,919  
Shares, Outstanding, Ending Balance at Jan. 31, 2026 0 3,618,907           25,331,803
Net loss 48,726 42,819 91,545  
Ending balance, value at Apr. 30, 2026 $ 0 $ 361 $ 0 $ 6,134,805 $ (3,482,130) $ 27,428 $ 2,680,464  
Shares, Outstanding, Ending Balance at Apr. 30, 2026 0 3,618,907           25,331,803
[1] All common stock share and per share amounts for all periods presented have been retroactively restated to give effect to the reverse stock split.